CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 1,862,286 | $27,376,000 | 8.48% |
| Vivo Capital, LLC | 3,320,801 | $48,816,000 | 4.42% |
| Burrage Capital Management LLC | 282,272 | $4,022,000 | 3.96% |
| Opaleye Management Inc. | 368,750 | $5,421,000 | 1.44% |
| Perceptive Advisors | 2,587,953 | $38,042,000 | 0.99% |
| RA Capital Management | 1,961,209 | $28,830,000 | 0.91% |
| New Leaf Venture Partners, L.L.C. | 141,000 | $2,073,000 | 0.62% |
| EcoR1 Capital, LLC | 350,000 | $5,145,000 | 0.54% |
| Orbimed Advisors | 2,039,282 | $29,977,000 | 0.50% |
| Eventide Asset Management | 947,000 | $13,921,000 | 0.45% |